Merus BV
Biotechnology
Healthcare
MRUS
69.02 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
68.68
52 week high
69.80
high
70.38
52 week low
0.00
low
67.79
growth
37.35 %
previous Close
69.19
P/E ratio
-49
market cap
3.95 B
div yield
0
usd
Mar 2025
qoq
revenue
26.49 M
189.80 %
net incoming
-96.47 M
-211.98 %
eps
-1.40 %
-185.71 %
eps surprise
-31.63 %
net profit margin
-364.22 %
-25.00 %
operating incoming
-75.74 M
14.56 %
net change in cash
-96.14 M
31.20 %
cash on hand
197 M
-32.76 %
cost of revenue
0.00 %
top top